Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,550 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: Los Angeles CA, San Antonio TX, Houston TX, St Louis MO,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase1, Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

for
Primary Immune Thrombocytopenia (ITP)
Location: Los Angeles CA, Oceanside CA, Phoenix AZ, Aurora CO,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06544499

Phase3, Recruiting

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

for
cGVHD
Location: Los Angeles CA, Duarte CA, Phoenix AZ,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05919511

Recruiting

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Los Angeles CA, Seattle WA, Houston TX, Madison WI,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06625593

Phase1, Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Los Angeles CA, Duarte CA, Denver CO, Houston TX,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05482893

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Los Angeles CA, Houston TX, Grand Rapids MI, Toledo OH,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06095583

Phase3, Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Los Angeles CA, South Pasadena CA, Torrance CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase3, Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

for
Metastatic Hepatocellular Carcinoma, Solid Tumors,
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06915753

Phase1, Recruiting

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

for
Acute Myeloid Leukemia
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT03921047

Recruiting

Blue Light Cystoscopy With Cysview® Registry

for
Bladder Cancer
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: Photocure

Sex: All

Age: 18+

Code: NCT02660645

Recruiting

Norris ORIEN Total Cancer Care

for
Cancer Risk, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT02970045

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Los Angeles CA, Orange CA, San Francisco CA, Gilbert AZ,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase1, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Los Angeles CA, La Jolla CA, West Valley City UT,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase1, Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Los Angeles CA, Santa Monica CA, Portland OR, Aurora CO,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase3, Recruiting

Core Biopsies for Establishing a Breast Tumor Tissue Repository

for
Breast Cancer
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT02250352

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Los Angeles CA, La Jolla CA, Portland OR, Denver CO,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase1, Phase2, Recruiting

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

for
GIST
Location: Los Angeles CA, Portland OR, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT05957367

Phase1, Phase2, Recruiting

Study of FID-022 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Los Angeles CA, Duarte CA, Tampa FL
Sponsor: Fulgent Pharma LLC.

Sex: All

Age: 18+

Code: NCT06694480

Phase1, Recruiting

Cognition and Motor Learning Post-stroke

for
Stroke, CVA (Cerebrovascular Accident)
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 45 - 70+

Code: NCT04829071

Early_phase1, Recruiting

The PerX360º System™ Registry

for
DDD
Location: Los Angeles CA, St. Augustine FL
Sponsor: Interventional Spine, Inc.

Sex: All

Age: 18+

Code: NCT01796535

Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles